Collectin-mediated antiviral host defense of the lung: Evidence from influenza virus infection of mice

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8204-8212

  Reading, Patrick C ^a   Morey, Leiana S ^a   Crouch, Erika C ^b   Anders, E Margot ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; LUNG SURFACTANT; MANNOSE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; VIRUS RESISTANCE; VIRUS VIRULENCE;

EID: 0030879806     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8204-8212.1997     Document Type: Article

References (56)

1. Anders, E. M., C. A. Hartley, and D. C. Jackson. 1990. Bovine and mouse serum β inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. USA 87:4485-4489.
2. Anders, E. M., C. A. Hartley, P. C. Reading, and R. A. B. Ezekowitz. 1994. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J. Gen. Virol. 75:615-622.
3. Baum, L. G., and J. C. Paulson. 1991. The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity. Virology 180:10-15.
4. Benne, C. A., B. Benaissa-Trouw, J. A. G. van Strijp, C. Kraaijeveld, and J. F. van Iwaarden. 1997. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur. J. Immunol. 27:886-890.
5. Benne, C. A., C. A. Kraaijeveld, J. A. G. van Strijp, E. Brouwer, M. Harmsen, J. Verhoef, L. M. G. van Golde, and J. F. van Iwaarden. 1995. Interactions of surfactant protein A with influenza viruses: binding and neutralization. J. Infect. Dis. 171:335-341.
6. Both, G. W., M. J. Sleigh, N. J. Cox, and A. P. Kendal. 1983. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: Multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J. Virol. 48:52-60.
7. Brown, L. E., C. W. Ward, and D. C. Jackson. 1982. Antigenic determinants of influenza virus hemagglutinin. IX. The carbohydrate side chains from an Asian strain. Mol. Immunol. 19:329-338.
8. Caton, A. J., G. G. Brownlee, J. W. Yewdell, and W. Gerhard. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-127.
9. Crouch, E., D. Chang, K. Rust, A. Persson, and J. Heuser. 1994. Recombinant pulmonary surfactant protein D. J. Biol. Chem. 269:15808-15813.
10. Crouch, E., D. Parghi, S.-F. Kuan, and A. Persson. 1992. Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am. Physiol. Soc. 263:L61-L66.
11. Deom, C. M., A. J. Caton, and I. T. Schulze. 1986. Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin. Proc. Natl. Acad. Sci. USA 83:3771-3775.
12. Ezekowitz, R. A. B., M. Kuhlman, J. E. Groopman, and R. A. Byrn. 1989. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169:185-196.
13. Fischer, P. B., S. Ellerman-Eriksen, S. Thiel, J. C. Jensenius, and S. C. Mogensen. 1994. Mannan-binding protein and bovine conglutinin mediate enhancement of herpes simplex virus type 2 infection in mice. Scand. J. Immunol. 39:439-445.
14. Hartley, C. A., D. C. Jackson, and E. M. Anders. 1992. Two distinct serum mannose-binding lectins function as β inhibitors of influenza virus: identification of bovine serum β inhibitor as conglutinin. J. Virol. 66:4358-4363.
15. Hartley, C. A., P. C. Reading, A. C. Ward, and E. M. Anders. 1997. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch. Virol. 142:75-88.
16. Hartshorn, K. L., E. C. Crouch, M. R. White, P. Eggleton, A. I. Tauber, D. Chang, and K. Sastry. 1994. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94:311-319.
17. Hartshorn, K. L., K. B. M. Reid, M. R. White, J. C. Jensenius, S. M. Morris, A. I. Tauber, and E. C. Crouch. 1996. Neutrophil deactivation by influenza A viruses: mechanisms of protection after opsonization with collectins and hemagglutination-inhibiting antibodies. Blood 87:3450-3461.
18. Hartshorn, K. L., K. Sastry, D. Brown, M. R. White, T. B. Okarma, Y.-M. Lee, and A. I. Tauber. 1993. Conglutinin acts as an opsonin for influenza A viruses. J. Immunol. 151:6265-6273.
19. Hartshorn, K. L., K. Sastry, M. R. White, E. M. Anders, M. Super, R. A. B. Ezekowitz, and A. I. Tauber. 1993. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Invest. 91:1414-1420.
20. Haurum, J. S., S. Thiel, I. M. Jones, P. B. Fischer, S. B. Laursen, and J. C. Jensenius. 1993. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7:1307-1313.
21. Holmskov, U., R. Malhotra, R. B. Sim, and J. Jensenius. 1994. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today 15:67-74.
22. Holt, P., U. Holmskov, S. Thiel, B. Teisner, P. Hoøjrup, and J. C. Jensenius. 1994. Purification and characterization of mannan-binding protein from mouse serum. Scand. J. Immunol. 39:202-208.
23. Honda, Y., H. Takahashi, Y. Kuroki, T. Akino, and S. Abe. 1996. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 109:1006-1009.
24. Hoppe, H.-J., and K. B. M. Reid. 1994. Collectins-soluble proteins containing collagenous regions and lectin domains - and their role in innate immunity. Protein Sci. 3:1143-1158.
25. Kilbourne, E. D. 1969. Future influenza vaccines and the use of genetic recombinants. Bull. W. H. O. 41:643-645.
26. Kilbourne, E. D., W. G. Laver, J. L. Schulman, and R. G. Webster. 1968. Antiviral activity of antiserum specific for an influenza virus neuraminidase. J. Virol. 2:281-288.
27. Kilbourne, E. D., J. L. Schulman, G. C. Schild, G. Schloer, J. Swanson, and D. Bucher. 1971. Correlated studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J. Infect. Dis. 124:449-462.
28. Kuan, S. F., K. F. Rust, and E. Crouch. 1992. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J. Clin. Invest. 90:97-106.
29. Lambré, C. R., H. Terzidis, A. Greffard, and R. G. Webster. 1990. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtiter plates coated with natural substrates. J. Immunol. Methods 135:49-57.
30. Malhotra, R., J. S. Haurum, S. Thiel, and R. B. Sim. 1994. Binding of human collectins (SP-A and MBP) to influenza virus. Biochem. J. 304:455-461.
31. Malhotra, R., S. Thiel, K. B. M. Reid, and R. B. Sim. 1990. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J. Exp. Med. 172:955-959.
32. Muster, T., B. Ferko, A. Klima, M. Purtscher, A. Trkola, P. Schulz, A. Grassauer, O. G. Engelhardt, A. Garcia-Sastre, P. Palese, and H. Katinger. 1995. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J. Virol. 69:6678-6686.
33. Naeve, C. W., V. S. Hinshaw, and R. G. Webster. 1984. Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J. Virol. 51:567-569.
34. Nakajima, S., Y. Takeuchi, and K. Nakajima. 1988. Location on the evolutionary tree of influenza H3 haemagglutinin genes of Japanese strains isolated during 1985-6 season. Epidemiol. Infect. 100:301-310.
35. Newton, S. E., G. M. Air, R. G. Webster, and W. G. Laver. 1983. Sequence of the hemagglutinin gene of influenza virus A/Memphis/1/71 and previously uncharacterized monoclonal antibody-derived variants. Virology 128:495-501.
36. Pyhälä, R., N. Ikonen, T. Forsten, S. Alanko, and L. Kinnunen. 1995. Evolution of the HA1 domain of human influenza A (H1N1) virus: loss of glycosylation sites and occurrence of herald and conserved strains. J. Gen. Virol. 76:205-210.
37. Pyhälä, R., N. Ikonen, M. Haanpää, and L. Kinnunen. 1996. HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains. Arch. Virol. 141:1033-1046.
38. Reading, P. C., C. A. Hartley, R. A. B. Ezekowitz, and E. M. Anders. 1995. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem. Biophys. Res. Commun. 217:1128-1136.
39. Reading, P. C., J. L. Miller, and E. M. Anders. Unpublished data.
40. Rocha, E., N. J. Cox, R. A. Black, M. W. Harmon, C. J. Harrison, and A. P. Kendal. 1991. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J. Virol. 65:2340-2350.
41. Rocha, E. P., X. Xu, H. E. Hall, J. R. Allen, H. L. Regnery, and N. J. Cox. 1993. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J. Gen. Virol. 74:2513-2518.
42. Sastry, K., K. Zahedi, J.-M. Lelias, A. S. Whitehead, and R. A. B. Ezekowitz. 1991. Molecular characterization of the mouse mannose-binding proteins. The mannose-binding protein A but not C is an acute phase reactant. J. Immunol. 147:692-697.
43. Schulman, J. L. 1969. The role of antineuraminidase antibody in immunity to influenza virus infection. Bull. W.H.O 41:647-650.
44. Simonsen, L., M. J. Clark, G. D. Williamson, D. F. Stroup, N. H. Arden, and L. B. Schonberger. The impact of influenza epidemics on mortality: Introducing a severity index. Am. J. Public Health, in press.
45. Skehel, J. J., D. J. Stevens, R. S. Daniels, A. R. Douglas, M. Knossow, I. A. Wilson, and D. C. Wiley. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 81:1779-1783.
46. Sumiya, M., M. Super, T. Tabona, R. J. Levinsky, T. Arai, M. W. Turner, and J. A. Summerfield. 1991. Molecular basis of opsonic defect in immunodeficient children. Lancet 337:1569-1570.
47. Summerfield, J. A. 1995. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 345:886-889.
48. Super, M., S. Thiel, J. Lu, R. J. Levinsky, and M. W. Turner. 1989. Association of low levels of a mannan-binding protein with a common defect of opsonisation. Lancet ii:1236-1239.
49. Thiel, S., and K. B. M. Reid. 1989. Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Lett. 250:78-84.
50. Turner, M. W. 1996. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17:532-540.
51. Verhoeyen, M., R. Fang, W. Min Jou, R. Devos, D. Huylebroeck, E. Saman, and W. Fiers. 1980. Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Nature (London) 286:771-776.
52. Ward, C. W., L. E. Brown, J. C. Downie, and D. C. Jackson. 1981. Antigenic determinants of influenza virus hemagglutinin. VII. The carbohydrate side chains of A/Memphis/102/72 hemagglutinin heavy chain which cross-react with host antigen. Virology 108:71-79.
53. Ward, C. W., and T. A. Dopheide. 1981. Amino acid sequence and oligosaccharide distribution of the hemagglutinin from an early Hong Kong influenza virus variant A/Aichi/2/68 (X-31). Biochem. J. 193:953-962.
54. Webster, R. G., Y. Kawaoka, and W. J. Bean. 1986. Molecular changes in A/chicken/Pennsylvania/83 (H5N2) influenza virus associated with acquisition of virulence. Virology 149:165-173.
55. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. The haemagglutinin membrane glycoprotein of influenza virus: structure at 3 Å resolution. Nature 289:366-373.
56. Wong, C. J., J. Akiyama, L. Allen, and S. Hawgood. 1996. Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse. Pediatr. Res. 39:930-937.